ISB News

‘Demystifying Disease, Democratizing Health Care’

In the Feb. 26, 2014, issue of Science Translational Medicine, Dr. Lee Hood and Dr. Nathan Price, of Institute for Systems Biology, deliver an editorial stating the vision of the 100K Wellness Project. The project will track health-related data types for 100K individuals longitudinally over the course of 20-30 or more years.

"Unsustainable cost increases threaten the global health care system, and further progress is stymied more by societal than technological factors. Only by engaging health care consumers (that is, patients) as pioneers who provide both health-related data and insights into pathophysiology can we meet these societal challenges and thus accelerate the pace of biomedical innovation. "

– Drs. Lee Hood and Nathan Price, Science Translational Medicine

To read the full editorial, please visit Science Translational Medicine or download the PDF.

To learn more about the 100K Wellness Project, please visit our research site.

Recent Articles

  • Spotlight on ISB Education graphic

    2023-24 School Year ISB Education Highlights

    Each month throughout the 2023-2024 academic year, we will highlight some of the top projects the ISB Education team is working on. In March, ISB Education highlights include a paper published in a Nature Portfolio journal, two events for science/STEM leaders, and more.

  • STEM Program Models for Students from Historically Marginalized Communities

    A new study unveils important insights and actionable protocols into providing equitable STEM experiences for high school students from historically marginalized communities. The research highlights the transformative power of informal STEM learning and the ease with which many organizations could provide these opportunities.

  • Common Immune Response Protective Across Many Diseases

    Infection, autoimmunity and cancer account for 40 percent of deaths worldwide. In a Cell Reports paper, ISB researchers detail how the human immune system works in common ways across diseases – findings that offer promising avenues for exploring multi-disease therapeutic strategies.